ArticleBrain : a journal of neurology2018

Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.

Haikun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.